Skip to content

Scott S. Tykodi

University of Washington

2 papers in the Anchorcite directory, published between 2012 and 2015, cited 13,967 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Julie Renee Brahmer · 1 paper
  • Laura Q.M. Chow · 1 paper
  • Wen‐Jen Hwu · 1 paper
  • Suzanne Louise Topalian · 1 paper
  • Patrick Hwu · 1 paper
  • Charles G. Drake · 1 paper
  • Luis H. Camacho · 1 paper
  • John Sae Wook Kauh · 1 paper

Papers

  1. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerNew England Journal of Medicine · 2012 · 8,054 citations

    BACKGROUND: Programmed death 1 (PD-1) protein, a T-cell coinhibitory receptor, and one of its ligands, PD-L1, play a pivotal role in the ability of tumor cells to evade the host's immune system. Blockade of interactions between PD-1 and PD-L1 enhances…

  2. Nivolumab versus Everolimus in Advanced Renal-Cell CarcinomaNew England Journal of Medicine · 2015 · 5,913 citations

    BACKGROUND: Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated with encouraging overall survival in uncontrolled studies involving previously treated patients with advanced renal-cell carcinoma. This randomized, open-label, phase 3 study compared nivolumab with everolimus in patients with renal-cell…

Metadata from OpenAlex (CC0).